See p. 4-6. AZT, ddI, ddC combinations at FDA advisory hearing. See p. 9-15. Protease inhibitors and nucleoside combinations, or, Alice in Gaithersburg. Three days that shook the world.
Optimism rises on combination therapy and protease inhibitor data.
An interview with David A. Cooper, MD, DSc. See p. 19-20. Highlights from the FDA antiviral drugs advisory committee meetings, February 27 - March 1, 1996. See p. 11, 13. Let there be drugs.